The DOI matches its Crossref record; 50 of the 54 references it cites were found in a registry or an index.
The Cost of Relapse for Patients with a Manic/Mixed Episode of Bipolar Disorder in the EMBLEM Study
Abstract
Background Bipolar disorder (BD) is characterized by episodes of mania and depression. The debilitating symptoms during an acute episode require intensive treatment, frequently leading to inpatient psychiatric care, which places significant demands on health and social care systems and incurs substantial costs. However, no study to date has estimated the economic impact of relapse. Objectives To estimate the direct costs associated with relapse in the treatment of BD following an acute manic or mixed episode over a 21-month follow-up period in routine clinical practice in Europe, using data from a large, prospective, observational study. Methods EMBLEM was a prospective, observational study on the outcomes of patients with a manic/mixed episode of BD conducted in 14 European countries. Patients eligible for analysis were those enrolled in the 21-month maintenance phase of the study, following the 3-month acute phase. Relapse was defined as achieving any one of the following criteria: (i) at least a one-point increase in Clinical Global Impression - Bipolar Disorder (CGI-BP) overall score from the previous visit, with a final rating of > or =4; (ii) inpatient admission for an acute episode of BD; or (iii) psychiatrists' confirmation of relapse. Data on healthcare resource use were recorded retrospectively for the four respective periods (3-6, 6-12, 12-18 and 18-24 month visits). Multivariate analyses were performed to compare the cost of resource use (inpatient stay, day care,…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Risks for hospitalization, suicide, and lost productivity are also increased with non‐adherence or discontinuation.350, 351, 352”
Citations
Cites
An Introduction to the Bootstrap
Efron, B., & Tibshirani, R. J. (1994) · doi:10.1201/9780429246593 · Cited by 40,500
An Introduction to the Bootstrap
Efron, B., & Tibshirani, R. J. (1993) · doi:10.1007/978-1-4899-4541-9 · Cited by 21,230
Multiple Imputation for Nonresponse in Surveys
Rubin, D. B. (1987) · Wiley Series in Probability and Statistics · doi:10.1002/9780470316696 · Cited by 20,701
Statistical Analysis With Missing Data
Lahiff, M., Little, R. J. A., & Rubin, D. B. (1989) · Journal of the American Statistical Association · doi:10.2307/2289883 · Cited by 17,265
Silva, J. M. C. S., & Tenreyro, S. (2006) · The Review of Economics and Statistics · doi:10.1162/rest.88.4.641 · Cited by 6,408
Analysis of Incomplete Multivariate Data
Schafer, J. L. (1997) · doi:10.1201/9781439821862 · Cited by 6,012
Analysis of Incomplete Multivariate Data
Booth, D. E. (2000) · Technometrics · doi:10.1080/00401706.2000.10486013 · Cited by 5,627
Yatham, L., & Malhi, G. (2011) · Oxford University Press eBooks · doi:10.1093/med/9780199562305.001.0001 · Cited by 3,506
(1958) · Journal of the American Pharmaceutical Association (Scientific ed.) · doi:10.1002/jps.3030470133 · Cited by 2,489
Statistical Analysis with Missing Data.
Chatfield, C., Little, R. J. A., & Rubin, D. B. (1988) · Journal of the Royal Statistical Society. Series A (Statistics in Society) · doi:10.2307/2982783 · Cited by 2,202
Research works printed but not linked: 4
- Curtis L. Unit costs of health and social care 2008. Kent: University of Kent, 2008
- American Psychiatric Association. Diagnostic and statistical manual ofmental disorders. 4th ed, text revision (DSM-IVTR). Washington, DC: APA, 2000
- Stata Corp. Stata statistical software: release 10. College Station (TX): StataCorp LP, 2007
- Goetz I, Tohen M, Reed C, et al. Functional impairment in patients with mania: baseline results of the EMBLEM study. Bipolar Disord 2006; 8: 1–8
Cited by
Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Bond, D. J., Frey, B. N., Sharma, V., Goldstein, B. I., Rej, S., Beaulieu, S., et al. (2018) · Bipolar Disorders · doi:10.1111/bdi.12609 · Cited by 1,852
Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Beaulieu, S., Alda, M., O’Donovan, C., MacQueen, G., McIntyre, R. S., Sharma, V., et al. (2013) · Bipolar Disorders · doi:10.1111/bdi.12025 · Cited by 1,217
Vázquez, G. H., Holtzman, J. N., Lolich, M., Ketter, T. A., & Baldessarini, R. J. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.07.013 · Cited by 102
Public health significance of bipolar disorder: implications for early intervention and prevention
Conus, P., Macneil, C. A., & McGorry, P. D. (2013) · Bipolar Disorders · doi:10.1111/bdi.12137 · Cited by 89
Smith, L., Johns, L., & Mitchell, R. (2017) · Bipolar Disorders · doi:10.1111/bdi.12520 · Cited by 52
Metadata
- Authors
- Hong, J., Reed, C., Novick, D., Haro, J. M., Windmeijer, F., & Knapp, M.
- Affiliations
- Eli Lilly (United Kingdom) (GB)
- University of Bristol (GB)
- King's College London (GB)
- Corresponding author
- Hong, Jihyung
- Venue
- PharmacoEconomics
- Published
- 2010-07
- Volume
- 28
- Issue
- 7
- Pages
- 555-566
- ISSN
- 1170-7690 (ISSN-L)
- 1179-2027
- OpenAlex
- W1995804459
- Cited by
- 26
- References
- 54
- Citations by year
- 2025: 1 · 2024: 4 · 2023: 5 · 2021: 1 · 2019: 1 · 2018: 3 · 2017: 3 · 2015: 4 · 2013: 1 · 2012: 2
- FWCI
- 0.86
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- PharmacoEconomics (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Bristol Research (University of Bristol) (submittedVersion)
- Funders
- Eli Lilly and Company
- Economic and Social Research Council (ES/H005331/1)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Social Sciences › Psychology › Clinical Psychology › Psychiatric care and mental health services
- Keywords
- bipolar disorder, relapse, direct costs, manic episodes, mixed states, health care utilization, inpatient psychiatric hospitalization, maintenance phase, emblematics, economic burden, mental health care costs, drug costs, unit cost, sensitivity analysis, multiple imputation, missing data, routine clinical practice, Europe, United Kingdom
- MeSH terms
- Adult, Bipolar Disorder, Costs and Cost Analysis, Europe, Female, Follow-Up Studies, Humans, Male, Prospective Studies, Socioeconomic Factors, Multivariate Analysis, Treatment Outcome, Health Care Costs, Models, Economic, Secondary Prevention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Cost of Relapse for Patients with a Manic/Mixed Episode of Bipolar Disorder in the EMBLEM Study. https://app.cochat.ai/papers/10.2165/11535200-000000000-00000
- The paper
- Hong, J., Reed, C., Novick, D., Haro, J. M., Windmeijer, F., & Knapp, M. (2010). The Cost of Relapse for Patients with a Manic/Mixed Episode of Bipolar Disorder in the EMBLEM Study. PharmacoEconomics. https://doi.org/10.2165/11535200-000000000-00000
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.